Prison Hepatitis program shows promise in limiting spread of HCV

In an article published in the Journal of Correctional Health Care, researchers from the National Development and Research Institutes, Inc. (NDRI) reported on an evaluation of an intervention program within a prison system addressing Hepatitis C virus (HCV).

Findings include recommendations for increasing Hepatitis C education and staff training, and expanding peer educators programming.

Hepatitis C virus is the most common chronic blood transmitted infectious disease in the United States today. The incidence is even higher among inmates in correctional facilities, with about a 9 times greater rate of infection. In addition, previous studies indicated that among those in the general population with the virus, a third or more pass through a correctional facility within a year's period. For those maximizing the public health impact of preventive and treatment interventions, the correctional facility is a vital location; and for those running correctional facilities or setting policy in the criminal justice area, attention to the public health impact of Hepatitis C has become extremely important.

Researchers at NDRI examined the HCV-related educational, testing, and medical services offered within a drug treatment program at a correctional facility in California. The study describes the services offered, assesses client and staff perceptions of the advantages, benefits, and barriers to delivering services, and made recommendations for the future.

"This approach presents a tremendous opportunity to limit the spread of HCV," noted Dr. Shiela Strauss, one of the authors. Yet such programs do not exist at many correctional facilities. The authors also recommend the relatively low cost and sustainable approach of peer to peer educational programs to address this pressing public health challenge within the budget limitations of many correctional programs.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research suggests no need for yellow fever vaccine booster after initial dose